Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 18246049)

1.

Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.

Kang XL, Zou H, Pang LJ, Hu WH, Zhao J, Qi Y, Liu CX, Hu JM, Tang JX, Li HA, Liang WH, Yuan XL, Li F.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3636-47. eCollection 2015.

2.

Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Durinck S, Stawiski EW, Pavía-Jiménez A, Modrusan Z, Kapur P, Jaiswal BS, Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja KB, Chen YJ, Saleem S, Chaudhuri S, Heldens S, Jackson M, Peña-Llopis S, Guillory J, Toy K, Ha C, Harris CJ, Holloman E, Hill HM, Stinson J, Rivers CS, Janakiraman V, Wang W, Kinch LN, Grishin NV, Haverty PM, Chow B, Gehring JS, Reeder J, Pau G, Wu TD, Margulis V, Lotan Y, Sagalowsky A, Pedrosa I, de Sauvage FJ, Brugarolas J, Seshagiri S.

Nat Genet. 2015 Jan;47(1):13-21. doi: 10.1038/ng.3146. Epub 2014 Nov 17.

3.

Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.

Köhn L, Svenson U, Ljungberg B, Roos G.

Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):334-42. doi: 10.1097/PAI.0000000000000087.

4.

Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis.

Yokomizo A, Yamamoto K, Furuno K, Shiota M, Tatsugami K, Kuroiwa K, Naito S.

Oncol Lett. 2010 Nov;1(6):1073-1078. Epub 2010 Sep 23.

5.

Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis.

Bowen JM, Cates JM, Kash S, Itani D, Gonzalez A, Huang D, Oliveira A, Bridge JA.

Cancer Genet. 2012 May;205(5):249-54. doi: 10.1016/j.cancergen.2012.04.005.

6.

SAQC: SNP array quality control.

Yang HC, Lin HC, Kang M, Chen CH, Lin CW, Li LH, Wu JY, Chen YT, Pan WH.

BMC Bioinformatics. 2011 Apr 18;12:100. doi: 10.1186/1471-2105-12-100.

7.

Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy.

Richey SL, Ng C, Lim ZD, Jonasch E, Tannir NM.

J Clin Oncol. 2011 Mar 10;29(8):e203-5. doi: 10.1200/JCO.2010.31.6091. Epub 2010 Dec 20. No abstract available.

8.

Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.

Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, Fabio F, Hilsenbeck S, Creighton CJ, Jaffe ES, Lau CC.

J Hematol Oncol. 2009 Nov 12;2:47. doi: 10.1186/1756-8722-2-47.

9.

Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, Wu X.

Int J Cancer. 2009 Nov 15;125(10):2342-8. doi: 10.1002/ijc.24642.

10.

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.

Arsanious A, Bjarnason GA, Yousef GM.

Mol Cancer. 2009 Mar 17;8:20. doi: 10.1186/1476-4598-8-20. Review.

11.

Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors.

Hagenkord JM, Parwani AV, Lyons-Weiler MA, Alvarez K, Amato R, Gatalica Z, Gonzalez-Berjon JM, Peterson L, Dhir R, Monzon FA.

Diagn Pathol. 2008 Nov 6;3:44. doi: 10.1186/1746-1596-3-44.

12.

Contemporary epidemiology of renal cell cancer.

Chow WH, Devesa SS.

Cancer J. 2008 Sep-Oct;14(5):288-301. doi: 10.1097/PPO.0b013e3181867628.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk